RECOVER-SLEEP: Platform Protocol

NCT06404086 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

830

Enrollment

OTHER

Sponsor class

Conditions

Long COVID
Long COVID-19
Hypersomnia
Sleep Disturbance

Interventions

DRUG: Modafinil
DRUG: Modafinil Placebo
DRUG: Solriamfetol
DRUG: Solriamfetol Placebo
DRUG: Melatonin
DRUG: Melantonin Placebo
DEVICE: Tailored lighting (TL) Active
DEVICE: Tailored lighting (TL) Placebo

Sponsor

Duke University